{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T16:18:48Z","timestamp":1795105128473,"version":"4.10.3"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"7941","license":[{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T00:00:00Z","timestamp":1670976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2022,12,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    High-grade serous ovarian cancer (HGSOC) is an archetypal cancer of genomic instability\n                    <jats:sup>1\u20134<\/jats:sup>\n                    patterned by distinct mutational processes\n                    <jats:sup>5,6<\/jats:sup>\n                    , tumour heterogeneity\n                    <jats:sup>7\u20139<\/jats:sup>\n                    and intraperitoneal spread\n                    <jats:sup>7,8,10<\/jats:sup>\n                    . Immunotherapies have had limited efficacy in HGSOC\n                    <jats:sup>11\u201313<\/jats:sup>\n                    , highlighting an unmet need to assess how mutational processes and the anatomical sites of tumour foci determine the immunological states of the tumour microenvironment. Here we carried out an integrative analysis of whole-genome sequencing, single-cell RNA sequencing, digital histopathology and multiplexed immunofluorescence of 160 tumour sites from 42 treatment-naive patients with HGSOC. Homologous recombination-deficient HRD-Dup (\n                    <jats:italic>BRCA1<\/jats:italic>\n                    mutant-like) and HRD-Del (\n                    <jats:italic>BRCA2<\/jats:italic>\n                    mutant-like) tumours harboured inflammatory signalling and ongoing immunoediting, reflected in loss of HLA diversity and tumour infiltration with highly differentiated dysfunctional CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells. By contrast, foldback-inversion-bearing tumours exhibited elevated immunosuppressive TGF\u03b2 signalling and immune exclusion, with predominantly naive\/stem-like and memory T cells. Phenotypic state associations were specific to anatomical sites, highlighting compositional, topological and functional differences between adnexal tumours and distal peritoneal foci. Our findings implicate anatomical sites and mutational processes as determinants of evolutionary phenotypic divergence and immune resistance mechanisms in HGSOC. Our study provides a multi-omic cellular phenotype data substrate from which to develop and interpret future personalized immunotherapeutic approaches and early detection research.\n                  <\/jats:p>","DOI":"10.1038\/s41586-022-05496-1","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T12:02:52Z","timestamp":1671019372000},"page":"778-786","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":341,"title":["Ovarian cancer mutational processes drive site-specific immune evasion"],"prefix":"10.1038","volume":"612","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0427-2639","authenticated-orcid":false,"given":"Ignacio","family":"V\u00e1zquez-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Uhlitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Ceglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie L. P.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6889-8345","authenticated-orcid":false,"given":"Michelle","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeman","family":"Mohibullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Niyazov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvin Eric B.","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2426-5436","authenticated-orcid":false,"given":"Kevin M.","family":"Boehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Bojilova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1612-5644","authenticated-orcid":false,"given":"Tyler","family":"Funnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diljot","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliyahu","family":"Havasov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arfath","family":"Pasha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5596-4961","authenticated-orcid":false,"given":"Druv M.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Pourmaleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2663-6288","authenticated-orcid":false,"given":"Nicole","family":"Rusk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Vanguri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5524-4174","authenticated-orcid":false,"given":"Marc J.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen W.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vance","family":"Broach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis S.","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Da Cruz Paula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginger J.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1956-6106","authenticated-orcid":false,"given":"Matthew","family":"Lennon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Long Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Zivanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6723-2859","authenticated-orcid":false,"given":"Ritika","family":"Kundra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes","family":"Viale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh N.","family":"Derakhshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Geneslaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Issa Bhaloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Maroldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahelly","family":"Nunez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3748-8049","authenticated-orcid":false,"given":"Fresia","family":"Pareja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthe","family":"Stylianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Vahdatinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonina","family":"Bykov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel N.","family":"Grisham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5790-851X","authenticated-orcid":false,"given":"Ying L.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia","family":"Lakhman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Nikolovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjiong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3644-1687","authenticated-orcid":false,"given":"Andrea","family":"Schietinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1599-0433","authenticated-orcid":false,"given":"Travis J.","family":"Hollmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel F.","family":"Bakhoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Soslow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lora H.","family":"Ellenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem R.","family":"Abu-Rustum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Aghajanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire F.","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9927-1270","authenticated-orcid":false,"given":"Britta","family":"Weigelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0094-0161","authenticated-orcid":false,"given":"Dmitriy","family":"Zamarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6402-523X","authenticated-orcid":false,"given":"Sohrab P.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,14]]},"reference":[{"key":"5496_CR1","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nature14410","volume":"521","author":"A-M Patch","year":"2015","unstructured":"Patch, A.-M. et al. Whole-genome characterization of chemoresistant ovarian cancer. Nature 521, 489\u2013494 (2015).","journal-title":"Nature"},{"key":"5496_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41586-019-1913-9","volume":"578","author":"Y Li","year":"2020","unstructured":"Li, Y. et al. Patterns of somatic structural variation in human cancer genomes. Nature 578, 112\u2013121 (2020).","journal-title":"Nature"},{"key":"5496_CR3","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/s41586-022-04789-9","volume":"606","author":"RM Drews","year":"2022","unstructured":"Drews, R. M. et al. A pan-cancer compendium of chromosomal instability. Nature 606, 976\u2013983 (2022).","journal-title":"Nature"},{"key":"5496_CR4","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ng.3849","volume":"49","author":"YK Wang","year":"2017","unstructured":"Wang, Y. K. et al. Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes. Nat. Genet. 49, 856\u2013865 (2017).","journal-title":"Nat. Genet."},{"key":"5496_CR5","doi-asserted-by":"publisher","unstructured":"Funnell, T. et al. Single-cell genomic variation induced by mutational processes in cancer. Nature https:\/\/doi.org\/10.1038\/s41586-022-05249-0 (2022).","DOI":"10.1038\/s41586-022-05249-0"},{"key":"5496_CR6","doi-asserted-by":"publisher","first-page":"e1006799","DOI":"10.1371\/journal.pcbi.1006799","volume":"15","author":"T Funnell","year":"2019","unstructured":"Funnell, T. et al. Integrated structural variation and point mutation signatures in cancer genomes using correlated topic models. PLoS Comput. Biol. 15, e1006799 (2019).","journal-title":"PLoS Comput. Biol."},{"key":"5496_CR7","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/ng.3573","volume":"48","author":"A McPherson","year":"2016","unstructured":"McPherson, A. et al. Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer. Nat. Genet. 48, 758\u2013767 (2016).","journal-title":"Nat. Genet."},{"key":"5496_CR8","doi-asserted-by":"publisher","first-page":"e1001789","DOI":"10.1371\/journal.pmed.1001789","volume":"12","author":"RF Schwarz","year":"2015","unstructured":"Schwarz, R. F. et al. Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis. PLoS Med. 12, e1001789 (2015).","journal-title":"PLoS Med."},{"key":"5496_CR9","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/s41591-020-0926-0","volume":"26","author":"B Izar","year":"2020","unstructured":"Izar, B. et al. A single-cell landscape of high-grade serous ovarian cancer. Nat. Med. 26, 1271\u20131279 (2020).","journal-title":"Nat. Med."},{"key":"5496_CR10","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.cell.2018.03.073","volume":"173","author":"AW Zhang","year":"2018","unstructured":"Zhang, A. W. et al. Interfaces of malignant and immunologic clonal dynamics in ovarian cancer. Cell 173, 1755\u20131769 (2018).","journal-title":"Cell"},{"key":"5496_CR11","doi-asserted-by":"crossref","unstructured":"Liu, Y. L. et al. Mutations, homologous DNA repair deficiency, tumor mutational burden, and response to immune checkpoint inhibition in recurrent ovarian cancer. JCO Precis. Oncol. 4, PO.20.00069 (2020).","DOI":"10.1200\/PO.20.00069"},{"key":"5496_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ygyno.2020.06.025","volume":"159","author":"JA Ledermann","year":"2020","unstructured":"Ledermann, J. A. et al. Avelumab in combination with and\/or following chemotherapy vs chemotherapy alone in patients with previously untreated epithelial ovarian cancer: results from the phase 3 Javelin Ovarian 100 trial. Gynecol. Oncol. 159, 13\u201314 (2020).","journal-title":"Gynecol. Oncol."},{"key":"5496_CR13","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1200\/JCO.21.00306","volume":"39","author":"KN Moore","year":"2021","unstructured":"Moore, K. N. et al. Atezolizumab, bevacizumab, and chemotherapy for newly diagnosed stage III or IV ovarian cancer: placebo-controlled randomized phase III trial (IMagyn050\/GOG 3015\/ENGOT-OV39). J. Clin. Oncol. 39, 1842\u20131855 (2021).","journal-title":"J. Clin. Oncol."},{"key":"5496_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"The Cancer Genome Atlas Research Network.","year":"2011","unstructured":"The Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609\u2013615 (2011).","journal-title":"Nature"},{"key":"5496_CR15","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1158\/2159-8290.CD-15-0714","volume":"5","author":"PA Konstantinopoulos","year":"2015","unstructured":"Konstantinopoulos, P. A., Ceccaldi, R., Shapiro, G. I. & D\u2019Andrea, A. D. Homologous recombination deficiency: exploiting the fundamental vulnerability of ovarian cancer. Cancer Discov. 5, 1137\u20131154 (2015).","journal-title":"Cancer Discov."},{"key":"5496_CR16","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/s41588-018-0179-8","volume":"50","author":"G Macintyre","year":"2018","unstructured":"Macintyre, G. et al. Copy number signatures and mutational processes in ovarian carcinoma. Nat. Genet. 50, 1262\u20131270 (2018).","journal-title":"Nat. Genet."},{"key":"5496_CR17","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41586-019-1907-7","volume":"578","author":"M Gerstung","year":"2020","unstructured":"Gerstung, M. et al. The evolutionary history of 2,658 cancers. Nature 578, 122\u2013128 (2020).","journal-title":"Nature"},{"key":"5496_CR18","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nm.4292","volume":"23","author":"H Davies","year":"2017","unstructured":"Davies, H. et al. HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures. Nat. Med. 23, 517\u2013525 (2017).","journal-title":"Nat. Med."},{"key":"5496_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19406-4","volume":"11","author":"L Nguyen","year":"2020","unstructured":"Nguyen, L., Martens, J. W. M., Van Hoeck, A. & Cuppen, E. Pan-cancer landscape of homologous recombination deficiency. Nat. Commun. 11, 5584 (2020).","journal-title":"Nat. Commun."},{"key":"5496_CR20","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.ccell.2021.04.004","volume":"39","author":"M Hornburg","year":"2021","unstructured":"Hornburg, M. et al. Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer. Cancer Cell 39, 928\u2013944 (2021).","journal-title":"Cancer Cell"},{"key":"5496_CR21","doi-asserted-by":"publisher","first-page":"abe6474","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng, L. et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science 374, abe6474 (2021).","journal-title":"Science"},{"key":"5496_CR22","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/j.bcp.2006.05.017","volume":"72","author":"C Gebhardt","year":"2006","unstructured":"Gebhardt, C., N\u00e9meth, J., Angel, P. & Hess, J. S100A8 and S100A9 in inflammation and cancer. Biochem. Pharmacol. 72, 1622\u20131631 (2006).","journal-title":"Biochem. Pharmacol."},{"key":"5496_CR23","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fimmu.2014.00402","volume":"5","author":"SS Bohlson","year":"2014","unstructured":"Bohlson, S. S., O\u2019Conner, S. D., Hulsebus, H. J., Ho, M.-M. & Fraser, D. A. Complement, C1q, and C1q-related molecules regulate macrophage polarization. Front. Immunol. 5, 402 (2014).","journal-title":"Front. Immunol."},{"key":"5496_CR24","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.cell.2017.10.001","volume":"171","author":"N McGranahan","year":"2017","unstructured":"McGranahan, N. et al. Allele-specific HLA loss and immune escape in lung cancer evolution. Cell 171, 1259\u20131271 (2017).","journal-title":"Cell"},{"key":"5496_CR25","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0818","author":"S Iyer","year":"2020","unstructured":"Iyer, S. et al. Genetically defined syngeneic mouse models of ovarian cancer as tools for the discovery of combination immunotherapy. Cancer Discov. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0818 (2020).","journal-title":"Cancer Discov."},{"key":"5496_CR26","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-0455","author":"S Zhang","year":"2020","unstructured":"Zhang, S. et al. Genetically defined, syngeneic organoid platform for developing combination therapies for ovarian cancer. Cancer Discov. https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0455 (2020).","journal-title":"Cancer Discov."},{"key":"5496_CR27","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1016\/j.celrep.2018.11.054","volume":"25","author":"L Ding","year":"2018","unstructured":"Ding, L. et al. PARP inhibition elicits STING-dependent antitumor immunity in Brca1-deficient ovarian cancer. Cell Rep. 25, 2972\u20132980 (2018).","journal-title":"Cell Rep."},{"key":"5496_CR28","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/s43018-020-00139-8","volume":"1","author":"RM Samstein","year":"2021","unstructured":"Samstein, R. M. et al. Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy. Nat. Cancer 1, 1188\u20131203 (2021).","journal-title":"Nat. Cancer"},{"key":"5496_CR29","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nm.4333","volume":"23","author":"A Zehir","year":"2017","unstructured":"Zehir, A., Benayed, R., Shah, R. H., Syed, A. & Middha, S. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat. Med. 23, 703\u2013713 (2017).","journal-title":"Nat. Med."},{"key":"5496_CR30","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/bs.mie.2019.05.057","volume":"632","author":"Y Bykov","year":"2020","unstructured":"Bykov, Y., Kim, S. H. & Zamarin, D. Preparation of single cells from tumors for single-cell RNA sequencing. Methods Enzymol. 632, 295\u2013308 (2020).","journal-title":"Methods Enzymol."},{"key":"5496_CR31","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1002\/1878-0261.12813","volume":"15","author":"LA Moukarzel","year":"2021","unstructured":"Moukarzel, L. A. et al. The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas. Mol. Oncol. 15, 1024\u20131039 (2021).","journal-title":"Mol. Oncol."},{"key":"5496_CR32","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/modpathol.2011.183","volume":"25","author":"RA Soslow","year":"2012","unstructured":"Soslow, R. A. et al. Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma. Mod. Pathol. 25, 625\u2013636 (2012).","journal-title":"Mod. Pathol."},{"key":"5496_CR33","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1097\/PAS.0000000000000556","volume":"40","author":"YR Hussein","year":"2016","unstructured":"Hussein, Y. R. et al. Invasion patterns of metastatic extrauterine high-grade serous carcinoma with BRCA germline mutation and correlation with clinical outcomes. Am. J. Surg. Pathol. 40, 404\u2013409 (2016).","journal-title":"Am. J. Surg. Pathol."},{"key":"5496_CR34","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"5496_CR35","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive integration of single-cell data. Cell 177, 1888\u20131902 (2019).","journal-title":"Cell"},{"key":"5496_CR36","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s41592-019-0529-1","volume":"16","author":"AW Zhang","year":"2019","unstructured":"Zhang, A. W. et al. Probabilistic cell-type assignment of single-cell RNA-seq for tumor microenvironment profiling. Nat. Methods 16, 1007\u20131015 (2019).","journal-title":"Nat. Methods"},{"key":"5496_CR37","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1093\/bioinformatics\/btv715","volume":"32","author":"P Angerer","year":"2016","unstructured":"Angerer, P. et al. destiny: diffusion maps for large-scale single-cell data in R. Bioinformatics 32, 1241\u20131243 (2016).","journal-title":"Bioinformatics"},{"key":"5496_CR38","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky, I. et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019).","journal-title":"Nat. Methods"},{"key":"5496_CR39","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nature20123","volume":"539","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma. Nature 539, 309\u2013313 (2016).","journal-title":"Nature"},{"key":"5496_CR40","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189\u2013196 (2016).","journal-title":"Science"},{"key":"5496_CR41","doi-asserted-by":"crossref","unstructured":"Van der Leun, A. M. & Thommen, D. S. CD8+ T cell states in human cancer: insights from single-cell analysis. Nat. Rev. Cancer 20, 218\u2013232 (2020).","DOI":"10.1038\/s41568-019-0235-4"},{"key":"5496_CR42","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/bioinformatics\/bts271","volume":"28","author":"CT Saunders","year":"2012","unstructured":"Saunders, C. T. et al. Strelka: accurate somatic small-variant calling from sequenced tumor\u2013normal sample pairs. Bioinformatics 28, 1811\u20131817 (2012).","journal-title":"Bioinformatics"},{"key":"5496_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-6-r84","volume":"15","author":"RM Layer","year":"2014","unstructured":"Layer, R. M., Chiang, C., Quinlan, A. R. & Hall, I. M. LUMPY: a probabilistic framework for structural variant discovery. Genome Biol. 15, R84 (2014).","journal-title":"Genome Biol."},{"key":"5496_CR44","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/nmeth.3505","volume":"12","author":"C Chiang","year":"2015","unstructured":"Chiang, C. et al. SpeedSeq: ultra-fast personal genome analysis and interpretation. Nat. Methods 12, 966\u2013968 (2015).","journal-title":"Nat. Methods"},{"key":"5496_CR45","doi-asserted-by":"publisher","unstructured":"McPherson, A., Shah, S. & Cenk Sahinalp, S. deStruct: accurate rearrangement detection using breakpoint specific realignment. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/117523 (2017).","DOI":"10.1101\/117523"},{"key":"5496_CR46","doi-asserted-by":"publisher","first-page":"e1001138","DOI":"10.1371\/journal.pcbi.1001138","volume":"7","author":"A McPherson","year":"2011","unstructured":"McPherson, A. et al. deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data. PLoS Comput. Biol. 7, e1001138 (2011).","journal-title":"PLoS Comput. Biol."},{"key":"5496_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1267-2","volume":"18","author":"AW McPherson","year":"2017","unstructured":"McPherson, A. W. et al. ReMixT: clone-specific genomic structure estimation in cancer. Genome Biol. 18, 140 (2017).","journal-title":"Genome Biol."},{"key":"5496_CR48","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1101\/gr.180281.114","volume":"24","author":"G Ha","year":"2014","unstructured":"Ha, G. et al. TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data. Genome Res. 24, 1881\u20131893 (2014).","journal-title":"Genome Res."},{"key":"5496_CR49","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","volume":"17","author":"DT Cheng","year":"2015","unstructured":"Cheng, D. T. et al. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology. J. Mol. Diagn. 17, 251\u2013264 (2015).","journal-title":"J. Mol. Diagn."},{"key":"5496_CR50","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94\u2013101 (2020).","journal-title":"Nature"},{"key":"5496_CR51","doi-asserted-by":"crossref","unstructured":"Malzer, C. & Baum, M. A hybrid approach to hierarchical density-based cluster selection. in 2020 IEEE International Conference on Multisensor Fusion and Integration for Intelligent Systems 223\u2013228 (IEEE, 2020).","DOI":"10.1109\/MFI49285.2020.9235263"},{"key":"5496_CR52","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1093\/nar\/gkw520","volume":"44","author":"R Shen","year":"2016","unstructured":"Shen, R. & Seshan, V. E. FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. Nucleic Acids Res. 44, e131 (2016).","journal-title":"Nucleic Acids Res."},{"key":"5496_CR53","doi-asserted-by":"crossref","unstructured":"Huang, X. & Huang, Y. Cellsnp-lite: an efficient tool for genotyping single cells. Bioinformatics 37, 4569\u20134571 (2021).","DOI":"10.1093\/bioinformatics\/btab358"},{"key":"5496_CR54","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1200\/CCI.20.00108","volume":"5","author":"R Kundra","year":"2021","unstructured":"Kundra, R. et al. OncoTree: a cancer classification system for precision oncology. JCO Clin. Cancer Inform. 5, 221\u2013230 (2021).","journal-title":"JCO Clin. Cancer Inform."},{"key":"5496_CR55","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/nbt.3344","volume":"33","author":"SA Shukla","year":"2015","unstructured":"Shukla, S. A. et al. Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes. Nat. Biotechnol. 33, 1152\u20131158 (2015).","journal-title":"Nat. Biotechnol."},{"key":"5496_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."},{"key":"5496_CR57","doi-asserted-by":"crossref","unstructured":"Schmidt, U., Weigert, M., Broaddus, C. & Myers, G. Cell detection with star-convex polygons. in Medical Image Computing and Computer Assisted Intervention (eds Frangi, A. et al.) 265\u2013273 (Springer International Publishing, 2018).","DOI":"10.1007\/978-3-030-00934-2_30"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05496-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05496-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05496-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T03:06:13Z","timestamp":1671678373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-022-05496-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,14]]},"references-count":57,"journal-issue":{"issue":"7941","published-print":{"date-parts":[[2022,12,22]]}},"alternative-id":["5496"],"URL":"https:\/\/doi.org\/10.1038\/s41586-022-05496-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.08.24.454519","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,14]]},"assertion":[{"value":"20 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.P.S. is a shareholder of Imagia Canexia Health and a\u00a0consultant to AstraZeneca,\u00a0outside the scope of this study. D.Z. reports research funding to MSK from AstraZeneca, Genentech, Synthekine and Plexxikon; personal fees from Synlogic Therapeutics, Hookipa Biotech, Agenus, Synthekine, Memgen, Mana Therapeutics, Tessa Therapeutics and Xencor; and stock options from Accurius, Calidi Biotherapeutics and Immunos. D.Z. is an inventor on a patent concerning the use of Newcastle disease virus as a cancer therapeutic, licensed to Merck. C.F.F. reports research funding to the institution from Merck, AstraZeneca, Genentech\/Roche, Bristol Myers Squibb and Daiichi and uncompensated membership of a scientific advisory board for Merck and Genentech and is a consultant for OncLive, Aptitude Health, Bristol Myers Squibb and Seagen, all outside the scope of this manuscript. B.W. reports ad hoc membership of the scientific advisory board of Repare Therapeutics, outside the scope of the submitted work. C.A. reports grants from Clovis, Genentech, AbbVie and AstraZeneca and personal fees from Tesaro, Eisai\/Merck, Mersana Therapeutics, Roche\/Genentech, Abbvie, AstraZeneca\/Merck and Repare Therapeutics, outside the scope of the submitted work. N.R.A.-R. reports grants to MSK from Stryker\/Novadaq and GRAIL, outside the scope of the submitted work. D.S.C. is on the medical advisory board of Apyx Medical Co, Verthermia Acquio and Biom'up and is a stockholder of Intuitive Surgical and TransEnterix. R.N.G. reports funding from GSK, Novartis, Mateon Therapeutics, Corcept, Regeneron, Clovis, Context Therapeutics, EMD Serono, MCM Education, OncLive, Aptitude Health and Prime Oncology, outside the scope of this work. Y.L.L. reports research funding from AstraZeneca, GSK\/Tesaro and Tesaro Therapeutics outside the scope of this work. Y.L. consults for Calyx Clinical Trials Solutions and holds shares of Y-mAbs Therapeutics. T.J.H. receives research funding from Bristol Myers Squibb, Calico Labs and the Parker Institute for Cancer Immunotherapy. S.F.B. owns equity in, receives compensation from, and serves as a consultant and on the scientific advisory board and board of directors of Volastra Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}